Literature DB >> 11599897

The Sunbelt Melanoma Trial.

K M McMasters1.   

Abstract

The Sunbelt Melanoma Trial is a prospective randomized trial to evaluate the role of lymph node dissection and adjuvant interferon alfa-2b for patients with early lymph node metastases.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11599897

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


  6 in total

Review 1.  Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma.

Authors:  Athanassios Kyrgidis; Thrasivoulos Tzellos; Simone Mocellin; Zoe Apalla; Aimilios Lallas; Pierluigi Pilati; Alexander Stratigos
Journal:  Cochrane Database Syst Rev       Date:  2015-05-16

Review 2.  [Value of sentinel node biopsy considering melanoma management as an example].

Authors:  C Loquai; H Riemann; S Grabbe
Journal:  Urologe A       Date:  2005-06       Impact factor: 0.639

Review 3.  [Malignant head and neck melanoma: Part 2: Therapy].

Authors:  C Pföhler; T Vogt; C S L Müller
Journal:  HNO       Date:  2015-08       Impact factor: 1.284

Review 4.  Malignant melanoma (non-metastatic).

Authors:  Philip Savage
Journal:  BMJ Clin Evid       Date:  2007-06-01

5.  Performance of a 31-gene expression profile test in cutaneous melanomas of the head and neck.

Authors:  Brian R Gastman; Jonathan S Zager; Jane L Messina; Robert W Cook; Kyle R Covington; Brooke Middlebrook; Pedram Gerami; Jeffrey D Wayne; Sancy Leachman; John T Vetto
Journal:  Head Neck       Date:  2019-01-29       Impact factor: 3.147

6.  Current status of sentinel lymph node biopsy in solid malignancies.

Authors:  Amit Goyal; Robert E Mansel
Journal:  World J Surg Oncol       Date:  2004-04-24       Impact factor: 2.754
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.